Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Uniqure Ord Shs (NQ: QURE )

7.140 +0.360 (+5.31%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,121,455
Open 6.790
Bid (Size) 6.260 (4)
Ask (Size) 8.650 (5)
Prev. Close 6.780
Today's Range 6.550 - 7.140
52wk Range 5.490 - 27.12
Shares Outstanding 47,811,479
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry Disease
Patient enrollment expected to begin in first half of 2024 
From uniQure Inc.
Via GlobeNewswire
3 Micro-Cap Stocks That Could Be Moonshots
If you are hungry for high-risk returns, then these micro-cap stocks to buy could be your winning ticket to future yields. 
Via InvestorPlace

Performance

YTD
-67.31%
-67.31%
1 Month
+23.96%
+23.96%
3 Month
-18.12%
-18.12%
6 Month
-64.39%
-64.39%
1 Year
-72.84%
-72.84%

More News

Read More
uniQure Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
From uniQure Inc.
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why Shares of uniQure Are Up Thursday
Via The Motley Fool
uniQure Announces Major Presence at the European Society of Gene and Cell Therapy (ESGCT) Annual Meeting
From uniQure Inc.
Via GlobeNewswire
Gene Therapy Player UniQure To Lay Off 20% Of Workforce, Stop Parkinson's Study
Via Benzinga
uniQure Announces Strategic Reorganization to Reduce Operating Expenses and Support Advancement of Multiple Clinical-Stage Programs
From uniQure Inc.
Via GlobeNewswire
uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From uniQure Inc.
Via GlobeNewswire
Why Shares of uniQure Are Dropping Tuesday
Via The Motley Fool
Topics Stocks
Exposures US Equities
Analyst Expectations for uniQure's Future
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?
Via Investor's Business Daily
Exposures Product Safety
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-260 Gene Therapy for Refractory Mesial Temporal Lobe Epilepsy
From uniQure Inc.
Via GlobeNewswire
Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Airbnb, Blackstone Rise On News They'll Join S&P 500 Index
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
3 Tantalizing Stocks to Buy for Under $10
Via InvestorPlace
uniQure Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress
From uniQure Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.